(Q35978507)

11 August 2017

Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein (English)

1 reference

11 August 2017

1 reference

1 reference

Schlichtholz B

1

1 reference

11 August 2017

Trédaniel J

2

1 reference

11 August 2017

Lubin R

3

1 reference

11 August 2017

Zalcman G

4

1 reference

11 August 2017

Hirsch A

5

1 reference

11 August 2017

Soussi T

6

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 May 1994

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

69

1 reference

11 August 2017

809-816

1 reference

11 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1994.159

11 August 2017

0 references

cites work

Radioimmunoassay of the cellular protein p53 in mouse and human cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968913

Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968913

Evolutionary conservation of the biochemical properties of p53: specific interaction of Xenopus laevis p53 with simian virus 40 large T antigen and mammalian heat shock proteins 70

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968913

Structural aspects of the p53 protein in relation to gene evolution

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968913

Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968913

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968913

p53 mutations in human cancers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968913

Surgical treatment of lung cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968913

TP53 tumor suppressor gene: a model for investigating human mutagenesis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968913

Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968913

Chemotherapy of lung cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968913

Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968913

p53: a frequent target for genetic abnormalities in lung cancer.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968913

Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968913

The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968913

Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968913

High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968913

Analysis of the anti-p53 antibody response in cancer patients.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968913

Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968913

Production of human p53 specific monoclonal antibodies and their use in immunohistochemical studies of tumor cells

24 September 2018

1 reference

12 December 2020

Presence of circulating antibodies against cellular protein p53 in a notable proportion of children with B-cell lymphoma

1 reference

12 December 2020

p53 immunostaining as a marker of malignant disease in diagnostic cytopathology

1 reference

12 December 2020

The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern

1 reference

12 December 2020

Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies

1 reference

12 December 2020

p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking

1 reference

12 December 2020

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

12 December 2020

p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features

1 reference

12 December 2020

Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma

1 reference

12 December 2020

An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53

1 reference

12 December 2020

Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung

1 reference

12 December 2020

p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus

1 reference

12 December 2020

Insertion of a disulfide-containing neurotoxin into E.coil alkaline phosphatase: the hybrid retains both biological activities

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1994.159

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

1 reference